Joseph S. Katende
Entebbe, C, Uganda
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Clinical and microbiological features of critical Clade Ib mpox in adults with HIV during a Ugandan outbreak.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: April 16, 2026
Saliva versus lesion swabs for PCR diagnosis of acute-phase clade Ib mpox in Uganda: a prospective matched hospital cohort study.
Journal: The Lancet. Microbe
Published: December 14, 2025
Two Decades Later: Long-Term Multisystem Sequelae and Subclinical Organ Dysfunction in Sudan Ebola Virus (SUDV) Survivors of the 2000 Outbreak.
Journal: Viruses
Published: August 30, 2025
Resilience and residuals beyond containment - The hidden burden of Bundibugyo Ebola virus survivorship sixteen years on: A cross-sectional observational study.
Journal: New microbes and new infections
Published: June 14, 2025
Geographical Differences in SARS-CoV-2 Antibody Response Dynamics and Neutralisation Profiles to Mild COVID-19: Lessons from a UK-Uganda Comparison.
Journal: Vaccines
Published: January 27, 2025
Long-Term Immune Consequences of Initial SARS-CoV-2 A.23.1 Exposure: A Longitudinal Study of Antibody Responses and Cross-Neutralization in a Ugandan Cohort.
Journal: Vaccines
Published: December 18, 2024
The single-dose Janssen Ad26.COV2.S COVID-19 vaccine elicited robust and persistent anti-spike IgG antibody responses in a 12-month Ugandan cohort.
Journal: Frontiers in immunology
Published: February 10, 2024
Sustained S-IgG and S-IgA antibodies to Moderna's mRNA-1273 vaccine in a Sub-Saharan African cohort suggests need for booster timing reconsiderations.
Journal: Frontiers in immunology
Published: December 03, 2023
Persistent and robust antibody responses to ChAdOx1-S Oxford-AstraZeneca (ChAdOx1-S, Covishield) SARS-CoV-2 vaccine observed in Ugandans across varied baseline immune profiles.
Journal: PloS one
Published: November 07, 2023
The subdued post-boost spike-directed secondary IgG antibody response in Ugandan recipients of the Pfizer-BioNTech BNT162b2 vaccine has implications for local vaccination policies.
Journal: Frontiers in immunology
Published: October 21, 2023
An Optimised Indirect ELISA Protocol for Detection and Quantification of Anti-viral Antibodies in Human Plasma or Serum: A Case Study Using SARS-CoV-2.
Journal: Bio-protocol
Published: August 25, 2023
Last Updated: 09/26/2026